Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Tesla CEO Elon Musk calls for making weight loss drugs super low cost to improve American health, aligning with healthcare ...

Soon it will be the new year, which means new year’s resolutions — and a very common one is weight loss. People on social ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The childhood obesity epidemic in GCC countries has triggered a debate on the potential use of weight-loss medications such ...

Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

Dateline correspondent Josh Mankiewicz lost nearly 50 pounds decades ago, and over time, it returned. Now, after a second ...

A mum-of-two died after taking weight loss drugs to shed excess weight after a battle with cancer. Sarah Thompson, 34, was ...

As new research suggests those taking GLP-1 drugs have fewer hospitalisations for alcoholism, a leading specialist warns ...

Doctors might be slow to admit it, but Ozempic and other GLP-1 drugs are making dieting and exercise obsolete.

Mondelez International’s latest overture to Hershey underscores the challenges posed by high cocoa prices and penny-pinching consumers, which could make the company more open to a deal.